Search For "inactivated"
Covaxin safe for children aged 2-18 years, says Bharat Biotech
Updated : 3 years, 11 months ago IST
Hyderabad (Telangana) [India], June 17 (ANI): Bharat Biotech International Limited (BBIL) on Thursday announced that Covaxin, its whole-virion inactivated COVID-19 vaccine has proven to be safe, well-tolerated, and highly immunogenic in paediatric subjects in phase II/III study, said a press
Read More
Covaxin found to be safe, immunogenic in 2-18 age group in phase 2, 3 stud
Updated : 4 years, 4 months ago IST
Hyderabad (Telangana) [India], December 30 (ANI): Hyderabad based vaccine manufacturer Bharat Biotech on Thursday announced that Covaxin (BBV152) has been found to be "safe, well-tolerated, and immunogenic" in the age group of 2-18 years in phase II/III study, said a company's statement.
Read More
No data shows need for booster vaccines presently: Dr Gagandeep Kang
Updated : 4 years, 9 months ago IST
New Delhi [India], August 17 (ANI): Speaking about when a booster dose should be administered, Dr Gagandeep Kang, professor at Christian Medical College Vellore on Tuesday, said some countries that have used inactivated, vectored vaccines or mRNA vaccines have begun to offer a booster dose t
Read More
Plea in Delhi HC seeking stay on Phase II/III clinical trial of Covaxin in
Updated : 4 years, 11 months ago IST
New Delhi [India], June 3 (ANI): A Fresh application was moved in Delhi High Court on Thursday seeking to stay the operation of the order of Drugs Controller General of India (DCGI) for conducting phase II/III clinical trials of Whole Virion Inactivated Coronavirus Vaccine in the 2 to 18 yea
Read More
Two Indian vaccine candidates against COVID-19 in phase two trials: VK Pau
Updated : 5 years, 9 months ago IST
New Delhi [India], Aug 29 (ANI): Bharat Biotech's vaccine candidate based on inactivated virus procured by ICMR and Zydus Cadila's candidate based on viral DNA are two Indian COVID-19 vaccines in second phase trial, Niti Aayog member Dr Vinod K Paul said on Saturday.
Read More
World's first phase III clinical trial of COVID-19 inactivated vaccine beg
Updated : 5 years, 10 months ago IST
Abu Dhabi [UAE], July 16 (WAM/ANI): The first World Health Organisation (WHO) enlisted global clinical Phase III trial of Sinopharm CNBG's inactivated vaccine to combat COVID-19 has started in Abu Dhabi in the United Arab Emirates and has been inspired by the UAE Leadership's vision and comm
Read More
Panacea Biotec to collaborate with US-based Refana Inc for COVID-19 vaccin
Updated : 5 years, 11 months ago IST
New Delhi [India], June 10 (ANI): Biotechnology major Panacea Biotec said on Wednesday it is collaborating with Refana Inc of the United States to make a COVID-19 vaccine widely accessible around the world in an equitable manner through a joint venture company to be based in Ireland.
Read More
China's inactivated COVID-19 vaccine shows potent protection against SARS-
Updated : 5 years, 11 months ago IST
Beijing [China], June 9 (ANI): China's inactivated COVID-19 vaccine has shown protection against coronavirus infection in animal experiments, Xinhua reported citing a study published in the journal Cell.
Read More